Intrinsic Value of S&P & Nasdaq Contact Us

GRAIL, Inc. GRAL

NASDAQ Global Market

SharesGrow Score
56/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$88.00
+74.3%

GRAIL, Inc. (GRAL) current share price is $50.49. The gold spot price is $4,825.20 per troy ounce. Using the formula: GRAL in gold = $50.49 × 31.1035 ÷ $4,825.20 = 0.3255 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of GRAL when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding GRAL shares over the measured period.

GRAL in US Dollars
Gold in US Dollars
GRAL in Gold (grams per share)

Real Wealth Growth Rate

GRAL
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{GRAL}_{\text{gold}}(t) = \frac{P_{\text{GRAL}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{GRAL}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{GRAL}_{\text{gold}}^{(T)}}{\text{GRAL}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{GRAL}_\text{gold}^{(0)}$ = initial gold-price, $\text{GRAL}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

CNTA
CNTA
Centessa Pharmaceuticals plc
$39.59
+0.05%
CELC
CELC
Celcuity Inc.
$120.85
+0.37%
APGE
APGE
Apogee Therapeutics, Inc.
$88.47
+1.99%
XENE
XENE
Xenon Pharmaceuticals Inc.
$59.35
+1.28%
NVST
NVST
Envista Holdings Corp
$27.38
+1.75%
DYN
DYN
Dyne Therapeutics, Inc.
$19.81
+4.26%
IDYA
IDYA
IDEAYA Biosciences, Inc.
$32.35
-1.43%
SLNO
SLNO
Soleno Therapeutics, Inc.
$52.62
-0.04%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message